Antimelanogenic Effect of Urolithin A and Urolithin B, the Colonic Metabolites of Ellagic Acid, in B16 Melanoma Cells

Journal of Agricultural and Food Chemistry

Volumn 65, Issue 32, 2017, Pages 6870-6876

  Wang, Shang Ta ^a   Chang, Wei Chia ^a   Hsu, Chen ^a   Su, Nan Wei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

B16 melanoma cells; ellagic acid; melanin; tyrosinase; urolithin

Indexed keywords

BIOMOLECULES; CATALYST ACTIVITY; DERMATOLOGY; ELLAGIC ACID; MELANIN; ONCOLOGY;

ANTI-INFLAMMATORIES; ANTI-MELANOGENESIS; B16 MELANOMA; COMPETITIVE INHIBITION; MRNA EXPRESSION; TYROSINASE; TYROSINASE INHIBITORS; UROLITHIN;

METABOLITES;

3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE; COUMARIN DERIVATIVE; ELLAGIC ACID; ENZYME INHIBITOR; MELANIN; MONOPHENOL MONOOXYGENASE; UROLITHIN B;

ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; COLON; DRUG EFFECTS; EXPERIMENTAL MELANOMA; GENETICS; KINETICS; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLON; COUMARINS; ELLAGIC ACID; ENZYME INHIBITORS; KINETICS; MELANINS; MELANOMA, EXPERIMENTAL; MICE; MONOPHENOL MONOOXYGENASE;

EID: 85027403986     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.7b02442     Document Type: Article

References (43)

1. Sealy, R. C.; Hyde, J. S.; Felix, C. C.; Menon, I.; Prota, G. Eumelanins and pheomelanins: characterization by electron spin resonance spectroscopy Science 1982, 217, 545-547 10.1126/science.6283638
2. Pintus, F.; Matos, M. J.; Vilar, S.; Hripcsak, G.; Varela, C.; Uriarte, E.; Santana, L.; Borges, F.; Medda, R.; Di Petrillo, A. New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies Bioorg. Med. Chem. 2017, 25, 1687-1695 10.1016/j.bmc.2017.01.037
3. Parvez, S.; Kang, M.; Chung, H. S.; Cho, C.; Hong, M. C.; Shin, M. K.; Bae, H. Survey and mechanism of skin depigmenting and lightening agents Phytother. Res. 2006, 20, 921-934 10.1002/ptr.1954
4. Sapkota, K.; Roh, E.; Lee, E.; Ha, E.-M.; Yang, J.-H.; Lee, E.-S.; Kwon, Y.; Kim, Y.; Na, Y. Synthesis and anti-melanogenic activity of hydroxyphenyl benzyl ether analogues Bioorg. Med. Chem. 2011, 19, 2168-2175 10.1016/j.bmc.2011.02.044
5. Arima, M.; Nishizawa, H.; Takeuchi, K.; Deura, H.; Ishida, K. Agent containing an ellagic acid series compound for external application and use thereof. U.S. Patent 5,073,545 A, December 17, 1991.
6. Shimogaki, H.; Tanaka, Y.; Tamai, H.; Masuda, M. In vitro and in vivo evaluation of ellagic acid on melanogenesis inhibition Int. J. Cosmet. Sci. 2000, 22, 291-304 10.1046/j.1467-2494.2000.00023.x
7. Yoshimura, M.; Watanabe, Y.; Kasai, K.; Yamakoshi, J.; Koga, T. Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation Biosci., Biotechnol., Biochem. 2005, 69, 2368-2373 10.1271/bbb.69.2368
8. Seeram, N. P.; Lee, R.; Heber, D. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice Clin. Chim. Acta 2004, 348, 63-68 10.1016/j.cccn.2004.04.029
9. Hamad, A.-W. R.; Al-Momani, W. M.; Janakat, S.; Oran, S. A. Bioavailability of ellagic acid after single dose administration using HPLC Pakistan Journal of Nutrition 2009, 8, 1661-1664 10.3923/pjn.2009.1661.1664
10. Espín, J. C.; Larrosa, M.; García-Conesa, M. T.; Tomás-Barberán, F. Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far Evidence-Based Complementary and Alternative Medicine 2013, 2013, 270418 10.1155/2013/270418
11. Zhang, W.; Chen, J. H.; Aguilera-Barrantes, I.; Shiau, C. W.; Sheng, X.; Wang, L. S.; Stoner, G. D.; Huang, Y. W. Urolithin A suppresses the proliferation of endometrial cancer cells by mediating estrogen receptor-α-dependent gene expression Mol. Nutr. Food Res. 2016, 60, 2387-2395 10.1002/mnfr.201600048
12. Aguilar-Zárate, P.; Cruz-Hernandez, M.; Montañez, J.; Belmares-Cerda, R.; Aguilar, C. Bacterial tannases: production, properties and applications Revista Mexicana de Ingeniería Química 2014, 13, 63-74
13. Selma, M. V.; Beltrán, D.; García-Villalba, R.; Espín, J. C.; Tomás-Barberán, F. A. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species Food Funct. 2014, 5, 1779-1784 10.1039/C4FO00092G
14. Selma, M. V.; Tomás-Barberán, F. A.; Beltran, D.; García-Villalba, R.; Espín, J. C. Gordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut Int. J. Syst. Evol. Microbiol. 2014, 64, 2346-2352 10.1099/ijs.0.055095-0
15. García-Villalba, R.; Beltrán, D.; Espín, J. C.; Selma, M. V.; Tomás-Barberán, F. A. Time course production of urolithins from ellagic acid by human gut microbiota J. Agric. Food Chem. 2013, 61, 8797-8806 10.1021/jf402498b
16. Cerdá, B.; Tomás-Barberán, F. A.; Espín, J. C. Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability J. Agric. Food Chem. 2005, 53, 227-235 10.1021/jf049144d
17. Larrosa, M.; González-Sarrías, A.; García-Conesa, M. T.; Tomás-Barberán, F. A.; Espín, J. C. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities J. Agric. Food Chem. 2006, 54, 1611-1620 10.1021/jf0527403
18. Sala, R.; Mena, P.; Savi, M.; Brighenti, F.; Crozier, A.; Miragoli, M.; Stilli, D.; Del Rio, D. Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions J. Funct. Foods 2015, 15, 97-105 10.1016/j.jff.2015.03.019
19. Ryu, D.; Mouchiroud, L.; Andreux, P. A.; Katsyuba, E.; Moullan, N.; Nicolet-dit-Félix, A. A.; Williams, E. G.; Jha, P.; Sasso, G. L.; Huzard, D. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents Nat. Med. 2016, 22, 879 10.1038/nm.4132
20. Oka, M.; Nagai, H.; Ando, H.; Fukunaga, M.; Matsumura, M.; Araki, K.; Ogawa, W.; Miki, T.; Sakaue, M.; Tsukamoto, K. Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells J. Invest. Dermatol. 2000, 115, 699-703 10.1046/j.1523-1747.2000.00095.x
21. Itoh, K.; Hirata, N.; Masuda, M.; Naruto, S.; Murata, K.; Wakabayashi, K.; Matsuda, H. Inhibitory effects of Citrus hassaku extract and its flavanone glycosides on melanogenesis Biol. Pharm. Bull. 2009, 32, 410-415 10.1248/bpb.32.410
22. Chung, S. W.; Ha, Y. M.; Kim, Y. J.; Song, S.; Lee, H.; Suh, H.; Chung, H. Y. Inhibitory effects of 6-(3-hydroxyphenyl)-2-naphthol on tyrosinase activity and melanin synthesis Arch. Pharmacal Res. 2009, 32, 289-294 10.1007/s12272-009-1235-9
23. Hyun, S. K.; Lee, W.-H.; Jeong, D. M.; Kim, Y.; Choi, J. S. Inhibitory effects of kurarinol, kuraridinol, and trifolirhizin from Sophora flavescens on tyrosinase and melanin synthesis Biol. Pharm. Bull. 2008, 31, 154-158 10.1248/bpb.31.154
24. Liu-Smith, F.; Meyskens, F. L. Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma Mol. Nutr. Food Res. 2016, 60, 1264-1274 10.1002/mnfr.201500822
25. Yoon, N. Y.; Eom, T.-K.; Kim, M.-M.; Kim, S.-K. Inhibitory effect of phlorotannins isolated from Ecklonia cava on mushroom tyrosinase activity and melanin formation in mouse B16F10 melanoma cells J. Agric. Food Chem. 2009, 57, 4124-4129 10.1021/jf900006f
26. Yang, Y. M.; Son, Y. O.; Lee, S. A.; Jeon, Y. M.; Lee, J. C. Quercetin inhibits α-MSH-stimulated melanogenesis in B16F10 melanoma Cells Phytother. Res. 2011, 25, 1166-1173 10.1002/ptr.3417
27. Song, Y. C.; Lee, Y.; Kim, H. M.; Hyun, M. Y.; Lim, Y. Y.; Song, K. Y.; Kim, B. J. Berberine regulates melanin synthesis by activating PI3K/AKT, ERK and GSK3β in B16F10 melanoma cells Int. J. Mol. Med. 2015, 35, 1011-1016 10.3892/ijmm.2015.2113
28. Tu, C. X.; Lin, M.; Lu, S. S.; Qi, X. Y.; Zhang, R. X.; Zhang, Y. Y. Curcumin inhibits melanogenesis in human melanocytes Phytother. Res. 2012, 26, 174-179 10.1002/ptr.3517
29. Cerdá, B.; Espín, J. C.; Parra, S.; Martínez, P.; Tomás-Barberán, F. A. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans Eur. J. Nutr. 2004, 43, 205-220 10.1007/s00394-004-0461-7
30. González-Sarrías, A.; García-Villalba, R.; Núñez-Sánchez, M. á.; Tomé-Carneiro, J.; Zafrilla, P.; Mulero, J.; Tomás-Barberán, F. A.; Espín, J. C. Identifying the limits for ellagic acid bioavailability: A crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts J. Funct. Foods 2015, 19, 225-235 10.1016/j.jff.2015.09.019
31. Natella, F.; Leoni, G.; Maldini, M.; Natarelli, L.; Comitato, R.; Schonlau, F.; Virgili, F.; Canali, R. Absorption, metabolism, and effects at transcriptome level of a standardized French oak wood extract, Robuvit, in healthy volunteers: pilot study J. Agric. Food Chem. 2014, 62, 443-453 10.1021/jf403493a
32. Seeram, N. P.; Henning, S. M.; Zhang, Y.; Suchard, M.; Li, Z.; Heber, D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 h J. Nutr. 2006, 136, 2481-2485
33. Tomás-Barberán, F. A.; García-Villalba, R. o.; González-Sarrías, A.; Selma, M. V.; Espín, J. C. Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status J. Agric. Food Chem. 2014, 62, 6535-6538 10.1021/jf5024615
34. García-Muñoz, C.; Hernández, L.; Pérez, A.; Vaillant, F. Diversity of urinary excretion patterns of main ellagitannins' colonic metabolites after ingestion of tropical highland blackberry (Rubus adenotrichus) juice Food Res. Int. 2014, 55, 161-169 10.1016/j.foodres.2013.10.049
35. Chen, Q.-X.; Kubo, I. Kinetics of mushroom tyrosinase inhibition by quercetin J. Agric. Food Chem. 2002, 50, 4108-4112 10.1021/jf011378z
36. Maeda, K.; Fukuda, M. Arbutin: mechanism of its depigmenting action in human melanocyte culture J. Pharmacol. Exp. Ther. 1996, 276, 765-769
37. Kim, K. S.; Kim, J. A.; Eom, S. Y.; Lee, S. H.; Min, K. R.; Kim, Y. Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression Pigm. Cell Res. 2006, 19, 90-98 10.1111/j.1600-0749.2005.00281.x
38. Liu, X.; Osawa, T. Cis astaxanthin and especially 9-cis astaxanthin exhibits a higher antioxidant activity in vitro compared to the all-trans isomer Biochem. Biophys. Res. Commun. 2007, 357, 187-193 10.1016/j.bbrc.2007.03.120
39. Battaini, G.; Monzani, E.; Casella, L.; Santagostini, L.; Pagliarin, R. Inhibition of the catecholase activity of biomimetic dinuclear copper complexes by kojic acid JBIC, J. Biol. Inorg. Chem. 2000, 5, 262-268 10.1007/s007750050370
40. Tsuji-Naito, K.; Hatani, T.; Okada, T.; Tehara, T. Modulating effects of a novel skin-lightening agent, α-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products Bioorg. Med. Chem. 2007, 15, 1967-1975 10.1016/j.bmc.2006.12.042
41. Yong, G.; Leone, C.; Strothkamp, K. G. Agaricus bisporus metapotyrosinase: preparation, characterization, and conversion to mixed-metal derivatives of the binuclear site Biochemistry 1990, 29, 9684-9690 10.1021/bi00493a025
42. Chang, T.-S. An updated review of tyrosinase inhibitors Int. J. Mol. Sci. 2009, 10, 2440-2475 10.3390/ijms10062440
43. Hsu, K. D.; Chen, H. J.; Wang, C. S.; Lum, C. C.; Wu, S. P; Lin, S. P.; Cheng, K. C. Extract of Ganoderma formosanum mycelium as a highly potenttyrosinase inhibitor Sci. Rep. 2016, 6, 32584 10.1038/srep32854